economy
AstraZeneca holds talks with Bristol Myers Squibb over $400bn tie-up
Deal would create world's fourth-largest drugmaker by market value
TL;DR
- AstraZeneca and Bristol Myers Squibb are reportedly holding talks.
- The discussions are about a potential merger or tie-up.
- The combined company would be the fourth-largest drugmaker globally by market value.